↓ Skip to main content

Categorization and association analysis of risk factors for adverse drug events

Overview of attention for article published in European Journal of Clinical Pharmacology, December 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
4 X users

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
80 Mendeley
Title
Categorization and association analysis of risk factors for adverse drug events
Published in
European Journal of Clinical Pharmacology, December 2017
DOI 10.1007/s00228-017-2373-5
Pubmed ID
Authors

Lina Zhou, Anamika Paul Rupa

Abstract

Adverse drug events (ADE) are among the leading causes of morbidity and hospitalization. This review analyzes risk factors for ADE, particularly their categorizations and association patterns, the prevalence, severity, and preventability of ADE, and method characteristics of reviewed studies. Literature search was conducted via PubMed, Science Direct, CINAHL, and MEDLINE. A review was conducted of research articles that reported original data about specific risk factors for ADE since 2000. Data analyses were performed using Excel and R. We summarized 211 risk factors for ADE, and grouped them into five main categories: patient-, disease-, medication-, health service-, and genetics-related. Among them, medication- and disease-related risk factors were most frequently studied. We further classified risk factors within each main category into subtypes. Among them, polypharmacy, age, gender, central nervous system agents, comorbidity, service utilization, inappropriate use/change use of drugs, cardiovascular agents, and anti-infectives were most studied subtypes. An association analysis of risk factors uncovered many interesting patterns. The median prevalence, preventability, and severity rate of reported ADE was 19.5% (0.29%~86.2%), 36.2% (2.63%~91%), and 16% (0.01%~47.4%), respectively. This review introduced new categories and subtypes of risk factors for ADE. The broad and in-depth coverage of risk factors and their association patterns elucidate the complexity of risk factor analysis. Managing risk factors for ADE is crucial for improving patient safety, particularly for the elderly, comorbid, and polypharmacy patients. Some under-explored risk factors such as genetics, mental health and wellness, education, lifestyle, and physical environment invite future research.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 80 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 14%
Student > Ph. D. Student 9 11%
Student > Doctoral Student 8 10%
Student > Postgraduate 6 8%
Other 5 6%
Other 12 15%
Unknown 29 36%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 14 18%
Medicine and Dentistry 13 16%
Nursing and Health Professions 6 8%
Computer Science 4 5%
Psychology 3 4%
Other 7 9%
Unknown 33 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2018.
All research outputs
#13,222,401
of 23,011,300 outputs
Outputs from European Journal of Clinical Pharmacology
#1,866
of 2,570 outputs
Outputs of similar age
#207,953
of 439,767 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#23
of 35 outputs
Altmetric has tracked 23,011,300 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,570 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,767 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.